Followers

Friday, May 21, 2021

'India, Pfizer seek to bridge dispute over Covid vaccine indemnity'

India has not given any manufacturer of a Covid-19 vaccine indemnity against the costs of compensation for any severe side effects, which is a condition Pfizer has obtained in many countries where its shots have already been widely used, including Britain and the United States.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3hKTa0J

No comments:

Post a Comment

Dow soars over 1,300 pts, Sensex 900 pts

Indian markets surged on Tuesday, with the Sensex closing above 80,000 points, fueled by a global rally following Donald Trump's victory...